RA CAPITAL MANAGEMENT, L.P.

Holdings History for BRIGHT MINDS BIOSCIENCES INC. - Common Stock (DRUG)

Symbol: DRUG on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 206,427 shares
Security Ownership %: 2.9%

Shares, Excluding Options vs Price

Value, Excluding Options

RA Capital Management, L.P. ownership in BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG)

15 May 2025 - RA Capital Management, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 206,427 shares of BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG). This represents 2.9% ownership of the company. This is the first filing by RA CAPITAL MANAGEMENT, L.P. disclosing ownership of BRIGHT MINDS BIOSCIENCES INC. Common Stock (DRUG).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
RA Capital Management, L.P.	2.9%		$6,376,530	206,427			$30.89	13G/A	31 Mar 2025	15 May 2025, 16:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2025		-0.12%	$0	0	-206,427	-100%	$80.57	Q2 2025
31 Mar 2025	0.12%	-0.15%	$7,445,822	206,427	-254,402		$36.07	Q1 2025
31 Dec 2024	0.22%	+0.22%	$16,599,061	460,829	+460,829	NEW	$36.02	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.